KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) EBT Margin: 2009-2025

Historic EBT Margin for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to 11.65%.

  • Quest Diagnostics' EBT Margin fell 25.00% to 11.65% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.86%, marking a year-over-year increase of 19.00%. This contributed to the annual value of 11.90% for FY2024, which is 31.00% down from last year.
  • Per Quest Diagnostics' latest filing, its EBT Margin stood at 11.65% for Q3 2025, which was down 16.25% from 13.91% recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' EBT Margin registered a high of 32.04% during Q2 2021, and its lowest value of 4.67% during Q4 2022.
  • For the 3-year period, Quest Diagnostics' EBT Margin averaged around 12.04%, with its median value being 11.88% (2023).
  • Per our database at Business Quant, Quest Diagnostics' EBT Margin surged by 1,808bps in 2021 and then tumbled by 1,887bps in 2022.
  • Quest Diagnostics' EBT Margin (Quarterly) stood at 18.29% in 2021, then slumped by 1,362bps to 4.67% in 2022, then surged by 569bps to 10.36% in 2023, then soared by 105bps to 11.41% in 2024, then fell by 25bps to 11.65% in 2025.
  • Its EBT Margin stands at 11.65% for Q3 2025, versus 13.91% for Q2 2025 and 10.41% for Q1 2025.